Abbott Collaborates with NIH on Brain Initiative for Advancing Research on Neurological Disorders

 Abbott Collaborates with NIH on Brain Initiative for Advancing Research on Neurological Disorders

Abbott Collaborates with NIH on Brain Initiative for Advancing Research on Neurological Disorders

Shots:

  • Abbott to provide its neuromodulation technologies including deep brain stimulation (DBS), spinal cord stimulation (SCS), and dorsal root ganglion (DRG) therapy. NIH to utilize Abbott’s technology for exploring its applications in chronic pain and progressive movement disorders as Parkinson’s disease
  • The focus of the collaboration is to accelerate the application of Abbott’s neurostimulation therapies, exploring new avenues for neurological conditions
  • Abbott’s neuromodulation technologies determine the inner workings of the nervous system, allowing to explore the interaction of the brain with the human body in patients with neurological conditions

Click here to read full press release/ article | Ref: Abbott | Image: The Pharma Letter

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post